Olink Proteomics ISIN: US6807101000 Forum: Aktien User: roiberleiter

https://www.globenewswire.com/news-release/2022/11/10/2552958/0/en/Olink-reports-third-quarter-2022-financial-results.html

https://www.globenewswire.com/news-release/2023/02/21/2611942/0/en/Olink-reports-fourth-quarter-and-full-year-2022-financial-results.html

https://www.globenewswire.com/news-release/2023/02/28/2617012/0/en/Olink-establishes-agreement-with-Regeneron-Genetics-Center-to-scale-their-proteomics-efforts-potentially-enabling-a-new-era-of-drug-discovery.html

https://investors.olink.com/news-releases/news-release-details/olink-reports-first-quarter-2023-financial-results

https://investors.olink.com/news-releases/news-release-details/olink-reports-second-quarter-2023-financial-results

"Release of Olink® Analyze 3.1 streamlines proteomic" https://www.globenewswire.com/news-release/2022/06/28/2470273/0/en/Release-of-Olink-Analyze-3-1-streamlines-proteomic-analysis-to-connect-data-to-biological-insight.html

https://www.globenewswire.com/news-release/2022/06/02/2455143/0/en/Pharma-Foods-International-and-Olink-initiate-strategic-partnership-in-Japan.html

https://finance.yahoo.com/news/olink-reports-first-quarter-2022-110000942.html

https://www.prnewswire.co.uk/news-releases/tataa-biocenter-is-partnering-with-olink-and-illumina-to-offer-high-performance-proteomics-with-unprecedented-throughput-897504162.html

Olink Reports Q4 Loss Despite 60% Jump In Sales; Issues FY22 Guidance https://www.benzinga.com/node/25598778

Olink participates in one of the largest proteomics studies enabling new treatment options for patients with heart failure https://www.globenewswire.com/news-release/2021/12/02/2345025/0/en/Olink-participates-in-one-of-the-largest-proteomics-studies-enabling-new-treatment-options-for-patients-with-heart-failure.html

Olink® Explore 3072 high-throughput proteomics platform now available: Significantly expands Olink's protein library for biomarker discovery https://finance.yahoo.com/news/olink-explore-3072-high-throughput-130000854.html

Olink® Signature Q100 now available: A user friendly desktop instrument to broaden access to Olink’s multiplex protein analysis platform https://www.globenewswire.com/news-release/2021/11/23/2339761/0/en/Olink-Signature-Q100-now-available-A-user-friendly-desktop-instrument-to-broaden-access-to-Olink-s-multiplex-protein-analysis-platform.html ...today announced that it is now starting the delivery of Olink® Signature Q100, facilitating hands-on access for researchers to Olink technology with a new benchtop system dedicated to multiplex protein biomarker measurement.    ...

Psomagen, Inc. is partnering with Olink Proteomics, enabling unprecedented multi-omics clinical studies https://www.globenewswire.com/news-release/2021/11/11/2332613/0/en/Psomagen-Inc-is-partnering-with-Olink-Proteomics-enabling-unprecedented-multi-omics-clinical-studies.html

Olink reports third quarter 2021 financial results https://finance.yahoo.com/news/olink-reports-third-quarter-2021-120000627.html